In non-small-cell lung cancer, tumor patients had higher levels of TSP-2 in blood samples and primary tumor tissues compared to healthy controls, while the TSP-2 levels increased with advanced pT-stages [22,23]. This evidence concerns the gene THBS2 and neoplasm.